The diagnosis of soft tissue and bone tumors can be a significant challenge (even for experienced pathologists) because of their rarity, the broad morphological spectrum of mesenchymal tumors, and overlap with other soft tissue tumors and non-mesenchymal neoplasms. The discovery of specific immunohistochemical markers and molecular genetic alterations drives the evolution of soft tissue tumor classification. If you are a surgical pathologist who struggles with accurate diagnosis of these challenging neoplasms, this is the course for you!
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following faculty and coordinators reported no relevant financial relationships: Jason L. Hornick, M.D., Ph.D., Elizabeth G. Demicco, M.D., Ph.D., Brendan C. Dickson, M.D., MSc, G. Petur Nielsen, M.D.
USCAP staff associated with the development of content for this activity reported no relevant financial relationships.
Format : Downloadable Link
: USB Drive